DR5, CBL-b/c-CBL, and TRAF2 form the complexes in TRAIL-resistant gastric cancer cells that target CBL-b and c-CBL by inhibiting the interaction of TRAF2 with caspase-8 and subsequent caspase-8 multiubiquitination. The gene discussed is CBL; the disease is gastric cancer.